Literature DB >> 35501647

Insulin Resistance in Experimental Type 1 Diabetes Mellitus.

V V Ivanov1, E E Buyko2,3, A A Ufandeev2, K I Nevskaya2, V V Udut3, A P Zima2, T V Saprina2, E V Udut2.   

Abstract

Experimental type 1 diabetes mellitus (T1DM) was induced in rats by daily intraperitoneal injections of alloxan in a dose of 90 mg/kg for 4 days. For verification of insulin resistance, insulin tolerance test was performed in 2 weeks and the glucose utilization rate constant (KITT) was calculated. The rats demonstrated the main symptoms of T1DM: hypoinsulinemia, hyperglycemia, ketonemia, glucosuria, ketonuria, polydipsia, polyphagia, weight loss, and insulin resistance, as evidenced by a decrease in KITT. The serum content of free fatty acids and triacylglycerols significantly increased. The content of triacylglycerols increased in skeletal muscles and decreased in the liver. A negative linear correlation was found between KITT and triacylglycerol content in muscles. Thus, the development of insulin resistance in experimental T1DM in rats is associated with accumulation of triacylglycerols in skeletal muscles.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  free fatty acids; glucose utilization rate constant; insulin resistance; triacylglycerols; type 1 diabetes mellitus

Mesh:

Substances:

Year:  2022        PMID: 35501647     DOI: 10.1007/s10517-022-05458-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  10 in total

1.  Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes.

Authors:  Melanie Cree-Green; Bryan C Bergman; Eda Cengiz; Larry A Fox; Tamara S Hannon; Kellee Miller; Brandon Nathan; Laura Pyle; Darcy Kahn; Michael Tansey; Eileen Tichy; Eva Tsalikian; Ingrid Libman; Kristen J Nadeau
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 2.  Causes and metabolic consequences of Fatty liver.

Authors:  Norbert Stefan; Konstantinos Kantartzis; Hans-Ulrich Häring
Journal:  Endocr Rev       Date:  2008-08-21       Impact factor: 19.871

Review 3.  The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes.

Authors:  Justin M Gregory; Alan D Cherrington; Daniel J Moore
Journal:  Diabetes       Date:  2020-05       Impact factor: 9.461

Review 4.  Type 1 diabetes.

Authors:  Linda A DiMeglio; Carmella Evans-Molina; Richard A Oram
Journal:  Lancet       Date:  2018-06-16       Impact factor: 79.321

5.  Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

6.  Effect of L-arginine-nitric oxide system on the metabolism of essential fatty acids in chemical-induced diabetes mellitus.

Authors:  I K Mohan; U N Das
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2000-01       Impact factor: 4.006

Review 7.  Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?

Authors:  S J Cleland; B M Fisher; H M Colhoun; N Sattar; J R Petrie
Journal:  Diabetologia       Date:  2013-04-24       Impact factor: 10.122

Review 8.  Evaluation of insulin sensitivity in clinical practice and in research settings.

Authors:  Lais U Monzillo; Osama Hamdy
Journal:  Nutr Rev       Date:  2003-12       Impact factor: 7.110

9.  Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus.

Authors:  Peter Wolf; Paul Fellinger; Lorenz Pfleger; Sabina Smajis; Hannes Beiglböck; Martin Gajdošík; Christian-Heinz Anderwald; Siegfried Trattnig; Anton Luger; Yvonne Winhofer; Martin Krššák; Michael Krebs
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

Review 10.  On type 1 diabetes mellitus pathogenesis.

Authors:  Stavroula A Paschou; Nektaria Papadopoulou-Marketou; George P Chrousos; Christina Kanaka-Gantenbein
Journal:  Endocr Connect       Date:  2017-11-30       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.